Vident Advisory, LLC Bio Techne Corp Transaction History

Vident Advisory, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$46.66 - $58.38 $7,185 - $8,990	154 Added 1.15%	13,584 $699 Million
Q1 2025 May 15, 2025	BUY	$58.47 - $78.75 $158,979 - $214,121	2,719 Added 25.39%	13,430 $787 Million
Q4 2024 Feb 14, 2025	SELL	$66.37 - $78.17 $43,804 - $51,592	-660 Reduced 5.8%	10,711 $772 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $50,807 - $58,962	-716 Reduced 5.92%	11,371 $909 Million
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $2,546 - $3,450	-41 Reduced 0.34%	12,087 $866 Million

Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $220,571 - $257,711	3,343 Added 38.05%	12,128 $854 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $20,973 - $31,053	-397 Reduced 4.32%	8,785 $678 Million
Q3 2023 Feb 21, 2024	BUY	$67.52 - $89.42 $26,805 - $35,499	397 Added 4.52%	9,182 $625 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $619,968 - $821,054	9,182 New	9,182 $625 Million

662

162M

514K

347K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.33B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.